Capsule structure 500mg №60

Capsules gelatinous, blue; the contents of the capsules - powder whitish-cream color, the presence of conglomerates (lumps), associated with the features of the spatial structure; capsule size: No. 1 - for 250 mg; No. 0 - for 500 mg.
1 capsule contains Chondroitin sulfate sodium 250 or 500 mg;
excipient: talc - 10 mg;
Shell composition: gelatin, titanium dioxide, indigotin.
15 pieces in a blister, 4 blisters in a carton box.

P №013685 / 01-2002, 05.02.02

Mechanism of action

Struktum affects metabolic processes in hyaline and fibrous cartilage, reduces degenerative changes in the cartilage tissue of the joints, stimulates the biosynthesis of glycosaminoglycans. It slows down bone resorption and reduces Calcium loss, accelerates bone repair processes. When using the drug, Struktum reduces pain and improves mobility of the affected joints, while the therapeutic effect persists for a long time after the end of the course of therapy.

Indications and usage

 
- osteoarthrosis;
- osteocondritis of the spine.

Contraindications

 
- pregnancy;
- lactation (breastfeeding);
- Hypersensitivity to the drug.

For adults appoint 500 mg 2 times / day.
The recommended duration of the initial course of treatment is 6 months. It should be borne in mind that the therapeutic effect of the drug lasts for 3-5 months after its cancellation, depending on the location and stage of the disease. If necessary, it is possible to conduct repeated courses of treatment, the duration of which is set individually.
Capsules washed down with water.

Adverse reactions

Seldom: allergic reactions, nausea, diarrhea.

Pregnancy and breastfeeding

The drug Struktum is contraindicated for use during pregnancy and lactation (breastfeeding).

Special notes

Be wary of prescribing the drug for bleeding or bleeding tendency.

Overdosage

So far, no cases of overdose have been reported.

With the simultaneous use of the drug Struktum may enhance the effects of indirect anticoagulants, antiplatelet agents and fibrinolytics.

The drug should be stored out of reach of children at a temperature not exceeding 25 ° C.